From crying babies to breaking windows, machines are being taught how to listen
Cambridge Angels investing millions to fill funding void for global hopefuls
Government funds trial of artificial intelligence to help with breast cancer screenings
Novel Boost For Mobile Reliability
Eagle Genomics named Top 500 global deeptech startup
GeoSpock Wins Liverpool Mayor’s ‘Smart Cities Realized’ Transport Challenge
GeoSpock® – the extreme-scale, data integration company that provides analytics, builds insight, and enables predictions across space and time – today announced that it has secured the Smart Transport Award as part of the Liverpool Major’s Challenges for Smart Cities Realized.
Kate Hilyard joins Healx to drive the integration of AI with drug discovery for rare diseases
PervasID receives £1.6 million investment to progress RFID technology
SyndicateRoom CEO scoops CEO Excellence Award
Repositive strengthens senior management team for new growth phase
DefiniGEN strengthens Board with appointment of Professor Sir John Savill
Featurespace joins the 'Sunday Times' Hiscox Tech Track 100
Arecor secures £6m investment for clinical development of its diabetes portfolio
Arecor Ltd, the UK-based leader in developing superior biopharmaceuticals through the application of an innovative formulation technology platform, today announces that it has secured £6 million of investment from new and existing investors for the clinical development of the Company’s speciality pharma portfolio of proprietary diabetes products.
Undo appoints Barry Morris as CEO to lead growth phase
CCS welcomes Ontix to lead programme for Metnet 12Gbps unlicensed 60GHz mmWave backhaul
Eagle Genomics lands co-sell status as part of Microsoft for Startups Programme
Featurespace team shortlisted in 6 categories ahead of Women in IT Excellence Awards 2018
Apple chooses Cambridge company as a 'rising European gaming star'
Oxford vs Cambridge tech: A battle of innovation waged with start-ups in tech, science and AI
Healx raises $10m as investors back AI to find rare disease treatments faster
Cambridge, UK – 26th July, 2018 – Healx (https://healx.io), the Cambridge (UK) technology company developing breakthrough treatments for rare diseases, today announced a $10 million Series A funding round, led by Balderton Capital, Europe’s leading early-stage venture investor. Existing investors, Jonathan Milner and Amadeus Capital Partners also participated in the round.